SecureAuth Continues to Raise the Bar on Passwordless Authentication with New Access Control Methods
Aug 30, 2017 12:00 pm UTC| Business
IRVINE, Calif., Aug. 30, 2017 -- SecureAuth® Corp., the pioneer in advanced adaptive access control for user authentication, is giving organizations the ability to ditch the password with new authentication methods that...
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
Aug 30, 2017 12:00 pm UTC| Business
CAMBRIDGE, Mass., Aug. 30, 2017 -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient...
Determine, Inc. to Present at the 6th Annual Liolios Gateway Conference on September 7, 2017
Aug 30, 2017 12:00 pm UTC| Business
CARMEL, Ind., Aug. 30, 2017 -- Determine, Inc. (NASDAQ:DTRM) has been invited to present at the 2017 Gateway Conference, which is being held on September 6-7, 2017 at the Four Seasons Hotel San Francisco. Determine,...
Aug 30, 2017 12:00 pm UTC| Business
DELRAY BEACH, Fla., Aug. 30, 2017 -- PositiveID Corporation’s (OTCQB:PSID) ExcitePCR subsidiary today announced the FireflyDX-Portable™, a rechargeable, bookbag-sized, realtime pathogen detection system designed to...
Quotient Limited to Participate in the Morgan Stanley 15th Annual Global Healthcare Conference
Aug 30, 2017 12:00 pm UTC| Business
JERSEY, Channel Islands, Aug. 30, 2017 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chairman and Chief Executive Officer, Paul Cowan, will present at the...
Aug 30, 2017 12:00 pm UTC| Business
SAN FRANCISCO, Aug. 30, 2017 -- Nozomi Networks, the pioneer in real-time cybersecurity and operational visibility for industrial control systems (ICS), today announced that its Co-founder and Chief Product Officer...
Momenta Pharmaceuticals to Webcast Presentation at the 2017 Wells Fargo Healthcare Conference
Aug 30, 2017 12:00 pm UTC| Business
CAMBRIDGE, Mass., Aug. 30, 2017 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it plans to provide a...